Global Structural Heart Occluders Medical Device Pipeline Market Landscape Report 2021: Stage of Development, Segment, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Structural Heart Occluders - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

"Structural Heart Occluders - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart.

Scope

• Extensive coverage of the Structural Heart Occluders under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Structural Heart Occluders under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Structural Heart Occluders Overview

3 Products under Development

3.1 Structural Heart Occluders - Pipeline Products by Stage of Development

3.2 Structural Heart Occluders - Pipeline Products by Segment

3.3 Structural Heart Occluders - Pipeline Products by Territory

3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path

3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date

3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development

4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

5.1 Aegis Medical Innovations Inc. Company Overview

5.2 Aporo Biomedical, Inc. (Inactive) Company Overview

5.3 Append Medical Company Overview

5.4 atHeart Medical Company Overview

5.5 AuriGen Medical Ltd Company Overview

5.6 Boston Scientific Corp Company Overview

5.7 CARAG AG Company Overview

5.8 Cierra, Inc. (Inactive) Company Overview

5.9 Conformal Medical Inc Company Overview

5.10 Cor Habere Corp Company Overview

5.11 Dextera Surgical Inc Company Overview

5.12 Ension, Inc. Company Overview

5.13 Hansen Medical Inc (Inactive) Company Overview

5.14 Laminar Inc Company Overview

5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview

5.16 LuSeed Vascular Company Overview

5.17 Mayo Clinic Company Overview

5.18 Medtronic Plc Company Overview

5.19 Meril Life Sciences Pvt Ltd Company Overview

5.20 Micro Interventional Devices, Inc. Company Overview

5.21 MicroPort Scientific Corp Company Overview

5.22 Northwestern University Company Overview

5.23 Occlutech International AB Company Overview

5.24 SentreHEART Inc Company Overview

5.25 SeptRx, Inc. (Inactive) Company Overview

5.26 Shanghai HeartCare Medical Technology Co Ltd Company Overview

5.27 Sheba Medical Center Company Overview

5.28 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview

5.29 Swissimplant AG Company Overview

5.30 University of Minnesota Company Overview

5.31 Vascular Closure Systems Inc Company Overview

5.32 Vascular Concepts Ltd Company Overview

5.33 W. L. Gore & Associates Inc Company Overview

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/twij9x

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900